Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Delahunt

Showing results (81-90 of 300) with videos related to

Pageof 30
Sort By:
Pathology|December 5, 2017
Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendationsLars Egevad, Brett Delahunt, Glen Kristiansen, et al.
Pathology|October 17, 2022
Late recurrence of renal solitary fibrous tumour in the contralateral kidneyHemamali Samaratunga, Tony Gianduzzo, Joanna Perry-Keene, et al.
Pathology|December 5, 2013
5-Alpha reductase inhibitors and PSA screening for prostate cancerPaul R McKenzie, Brett Delahunt, James G Kench, et al.
Pathology|December 9, 2003
Renal dysplasia produced by obstructive uropathy in the fetal lambKevin C Pringle, Jane Zuccollo, Hiroaki Kitagawa, et al.
The American Journal of Surgical Pathology|July 2, 2022
In Reply: Intraductal Carcinoma of the Prostate and Nuclear SizeHemamali Samaratunga, Brett Delahunt, John W Yaxley, et al.
The American Journal of Surgical Pathology|July 15, 2021
Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic ParameterHemamali Samaratunga, Brett Delahunt, John W Yaxley, et al.
Scandinavian Journal of Urology|July 15, 2016
From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancerHemamali Samaratunga, Brett Delahunt, John Yaxley, et al.
Anticancer Research|March 25, 2010
Type 2 and clear cell papillary renal cell carcinoma, and tubulocystic carcinoma: a unifying conceptCatriona Brennan, John R Srigley, Clair Whelan, et al.
Pathology|September 5, 2024
Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigenHemamali Samaratunga, Brett Delahunt, Mats Olsson, et al.
Anticancer Research|August 21, 2003
Myxosarcoma of the right ventricle: an immunohistochemical and ultrastructural studyRupa N Maitra, David J McHaffie, J St John Wakefield, et al.
Pageof 30

Showing results (81-90 of 300) with videos related to

Sort By:
Pageof 30
Pathology|December 5, 2017
Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendationsLars Egevad, Brett Delahunt, Glen Kristiansen, et al.
Pathology|October 17, 2022
Late recurrence of renal solitary fibrous tumour in the contralateral kidneyHemamali Samaratunga, Tony Gianduzzo, Joanna Perry-Keene, et al.
Pathology|December 5, 2013
5-Alpha reductase inhibitors and PSA screening for prostate cancerPaul R McKenzie, Brett Delahunt, James G Kench, et al.
Pathology|December 9, 2003
Renal dysplasia produced by obstructive uropathy in the fetal lambKevin C Pringle, Jane Zuccollo, Hiroaki Kitagawa, et al.
The American Journal of Surgical Pathology|July 2, 2022
In Reply: Intraductal Carcinoma of the Prostate and Nuclear SizeHemamali Samaratunga, Brett Delahunt, John W Yaxley, et al.
The American Journal of Surgical Pathology|July 15, 2021
Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic ParameterHemamali Samaratunga, Brett Delahunt, John W Yaxley, et al.
Scandinavian Journal of Urology|July 15, 2016
From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancerHemamali Samaratunga, Brett Delahunt, John Yaxley, et al.
Anticancer Research|March 25, 2010
Type 2 and clear cell papillary renal cell carcinoma, and tubulocystic carcinoma: a unifying conceptCatriona Brennan, John R Srigley, Clair Whelan, et al.
Pathology|September 5, 2024
Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigenHemamali Samaratunga, Brett Delahunt, Mats Olsson, et al.
Anticancer Research|August 21, 2003
Myxosarcoma of the right ventricle: an immunohistochemical and ultrastructural studyRupa N Maitra, David J McHaffie, J St John Wakefield, et al.
Pageof 30